Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03075776
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
AKT | 10-DECARBOXYMETHYLACLACINOMYCIN T (DCMAT) | A | 1Q0R | 0.71 |  |
NGP | NOGALAMYCIN (PROTONATED FORM) | A | 1L0R | 0.71 | |
AP1 | {3-[3-(3,4-DIMETHOXY-PHENYL)-1- (1-{1-[2-(3,4,5-TRIMETHOXY-PHENYL)- BUTYRYL]-PIPERIDIN-2YL}-VINYLOXY)- PROPYL]-PHENOXY}-ACETIC ACID | A,B | 1BL4 | 0.74 | |
AKY | A,B,C,D | 2IPI | 0.71 | | |
AKA | 10-DECARBOXYMETHYLACLACINOMYCIN A (DCMAA) | A | 1Q0Z | 0.71 | |
NOD | N-ETHYLHYDROXY-DOXORUBICIN | A | 385D | 0.72 | |
DMM | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)- DOXORUBICIN | A | 215D | 0.75 | |
| DMM | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)- DOXORUBICIN | A | 235D | 0.75 | |
| DMM | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)- DOXORUBICIN | A | 234D | 0.75 | |
| DMM | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)- DOXORUBICIN | A,B | 2DES | 0.75 | |
HEH | HEDAMYCIN | A | 1JHI | 0.73 | |
NOV | NOVOBIOCIN | A,B | 1KIJ | 0.71 | |
| NOV | NOVOBIOCIN | A,B | 1S14 | 0.71 | |
| NOV | NOVOBIOCIN | A | 1AJ6 | 0.71 | |
CPB | 2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY- 8-(3-HYDROXY-1-METHYL-PIPERIDIN- 4-YL)-4H-BENZOPYRAN-4-ONE | A | 1E1Y | 0.7 | |
| CPB | 2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY- 8-(3-HYDROXY-1-METHYL-PIPERIDIN- 4-YL)-4H-BENZOPYRAN-4-ONE | A,B | 3BLR | 0.7 | |
| CPB | 2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY- 8-(3-HYDROXY-1-METHYL-PIPERIDIN- 4-YL)-4H-BENZOPYRAN-4-ONE | A | 1C8K | 0.7 | |
NGU | U-58872, HYDROXY DERIVATIVE OF NOGALAMYCIN | A,B | 1D22 | 0.73 | |
DM1 | DAUNOMYCIN | A | 152D | 0.71 | |
| DM1 | DAUNOMYCIN | A,B,C,D | 1O0K | 0.71 | |
| DM1 | DAUNOMYCIN | A | 1JO2 | 0.71 | |
| DM1 | DAUNOMYCIN | A,B | 308D | 0.71 | |
| DM1 | DAUNOMYCIN | A | 1D33 | 0.71 | |
| DM1 | DAUNOMYCIN | A | 110D | 0.71 | |
| DM1 | DAUNOMYCIN | A | 1D11 | 0.71 | |
| DM1 | DAUNOMYCIN | A | 427D | 0.71 | |
| DM1 | DAUNOMYCIN | A | 2D34 | 0.71 | |
| DM1 | DAUNOMYCIN | A | 3F8F | 0.71 | |
| DM1 | DAUNOMYCIN | A | 1D10 | 0.71 | |
| DM1 | DAUNOMYCIN | A | 1DA0 | 0.71 | |
NLX | (5A,17R)-4,5-EPOXY-3,14-DIHYDROXY- 17-METHYL-6-OXO-17-(2-PROPENYL)- MORPHINANIUM | A,B,C,D,E,F, G,H,I,J,K,L | 1MX9 | 0.78 | |
429 | 2-{4-[2-ACETYLAMINO-3-(4-CARBOXYMETHOXY- 3-HYDROXY-PHENYL)-PROPIONYLAMINO]- BUTOXY}-6-HYDROXY-BENZOIC ACID METHYL ESTER | A | 1QXK | 0.71 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1D15 | 0.71 | |
| DM6 | 4'-EPIDOXORUBICIN | A | 1D54 | 0.71 | |
| DM6 | 4'-EPIDOXORUBICIN | A | 1D58 | 0.71 | |
| DM6 | 4'-EPIDOXORUBICIN | A | 1QDA | 0.71 | |
DM2 | DOXORUBICIN | A | 2DR6 | 0.71 | |
| DM2 | DOXORUBICIN | A | 1P20 | 0.71 | |
| DM2 | DOXORUBICIN | A | 1I1E | 0.71 | |
| DM2 | DOXORUBICIN | A | 151D | 0.71 | |
| DM2 | DOXORUBICIN | A | 1D12 | 0.71 | |
| DM2 | DOXORUBICIN | A | 1DA9 | 0.71 | |
ERT | METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY- 7-METHOXY-6,11-DIOXO-4-{[2,3,6- TRIDEOXY-3-(DIMETHYLAMINO)-BETA- D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H- TETRACENE-1-CARBOXYLATE | A,B | 1TW2 | 0.72 | |
| ERT | METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY- 7-METHOXY-6,11-DIOXO-4-{[2,3,6- TRIDEOXY-3-(DIMETHYLAMINO)-BETA- D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H- TETRACENE-1-CARBOXYLATE | A,B | 1TW3 | 0.72 | |
MNG | MENOGARIL | A,B | 202D | 0.75 | |
FLQ | N-[6-(ACETYLAMINO)HEXYL]-3',6'- DIHYDROXY-3-OXO-3H-SPIRO[2-BENZOFURAN- 1,9'-XANTHENE]-6-CARBOXAMIDE | C | 2FDC | 0.75 | |
BDA | 4-METHYLBENZYL-N-BIS[DAUNOMYCIN] | A | 1AL9 | 0.74 | |
| BDA | 4-METHYLBENZYL-N-BIS[DAUNOMYCIN] | A | 1AGL | 0.74 | |
AAY | 8-[2-((2S)-4-HYDROXY-1-{[5-(HYDROXYMETHYL)- 6-METHOXY-2-NAPHTHYL]METHYL}-6- OXOPIPERIDIN-2-YL)ETHYL]-3,7-DIMETHYL- 1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN- 1-YL 2-METHYLBUTANOATE | A,B | 1XDD | 0.71 | |
DRA | 11-DEOXY-BETA-RHODOMYCIN | A,B | 1XDS | 0.71 | |
MAR | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1D36 | 0.7 | |
| MAR | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1R68 | 0.7 | |
| MAR | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1D35 | 0.7 | |
CMD | 3'-DESAMINO-3'-(3-CYANO-4-MORPHOLINYL)- DOXORUBICIN | A | 236D | 0.73 | |
BNR | BIS-DAUNORUBICIN | B | 1AMD | 0.72 | |
DM9 | N-HYDROXYMETHYL-N-(2-METHOXYETHYL)- DAUNOMYCIN | A | 482D | 0.72 | |
EH5 | N-(1-BENZYL-3-{[3-(1,3-DIOXO-1,3- DIHYDRO-ISOINDOL-2-YL)-PROPIONYL]- [2-(HEXAHYDRO-BENZO[1,3]DIOXOL- 5-YL)-ETHYL]-AMINO}-2-HYDROXY-PROPYL)- 4-BENZYLOXY-3,5-DIMETHOXY-BENZAMIDE | A | 1LF3 | 0.74 | |
DEO | A,B | 1ROS | 0.71 | | |
NGM | NOGALAMYCIN | A,B,C,D | 258D | 0.73 | |
| NGM | NOGALAMYCIN | A | 282D | 0.73 | |
| NGM | NOGALAMYCIN | A,B | 224D | 0.73 | |
| NGM | NOGALAMYCIN | A,B | 245D | 0.73 | |
| NGM | NOGALAMYCIN | A,B | 1QCH | 0.73 | |
| NGM | NOGALAMYCIN | A | 1D17 | 0.73 | |
| NGM | NOGALAMYCIN | A,B | 1D21 | 0.73 | |
| NGM | NOGALAMYCIN | A,B | 182D | 0.73 | |
DM3 | 6-DEOXYDAUNOMYCIN | A | 1D14 | 0.7 | |
GL8 | GALANTHAMINE DERIVATIVE | A | 1W4L | 0.7 | |
BA1 | BALANOL | A | 1BX6 | 0.72 | |
CX6 | 2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3- G]PYRROLO[2,1-B][1,3]BENZOXAZIN- 11-ONE | A,B,C,D,E,F | 2AL4 | 0.77 | |
C01 | (2S)-(4-ISOPROPYLPHENYL)[(2-METHYL- 3-OXO-5,7-DIPROPYL-2,3-DIHYDRO- 1,2-BENZISOXAZOL-6-YL)OXY]ACETATE | A | 1ZEO | 0.73 | |